Josep Julve
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 34
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 17
- Surgery top 5%
- Cholesterol and Lipid Metabolism 35
- Lipoproteins and Cardiovascular Health 30
- Clinical Biochemistry top 5%
- Biochemistry top 5%
-
- Lipid metabolism and disorders 22
-
- Peroxisome Proliferator-Activated Receptors 17
-
- Liver Disease Diagnosis and Treatment 12
-
- Drug Transport and Resistance Mechanisms 10
- Co-authors
- Francisco Blanco‐VacaJoan Carles Escolà‐GilJesús M. Martín‐CamposJordi Ordóñez‐LlanosFrancesc González‐SastreNoemí RotllánLídia CedóJosé Luís Sánchez-Quesada
- Journals
- Journal of Biological Chemistry (1 paper)The Journal of Immunology (1 paper)PLoS ONE (2 papers)
- Partner nations
- SpainUnited StatesFinland
In The Last Decade
Josep Julve
129 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 109
- Endocrinology, Diabetes and Metabolism 784
- Cancer Research 368
- Surgery 1.0k
- Clinical Biochemistry 143
- Biochemistry 142
Countries citing papers authored by Josep Julve
This map shows the geographic impact of Josep Julve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Julve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Julve more than expected).
Fields of papers citing papers by Josep Julve
This network shows the impact of papers produced by Josep Julve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Julve. The network helps show where Josep Julve may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Josep Julve, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 2 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 4 | |
| 16 | 2020 | 20 | |
| 17 | 2019 | 8 | |
| 18 | 2019 | 13 | |
| 19 | 2018 | 8 | |
| 20 | Diagnóstico de hiperquilomicronemia familiar debida a deficiencia de lipoproteinlipasa: estudio clínico, bioquímico y genético de un caso y análisis de las mutaciones identificadas en otros 10 casos | 2000 | 1 |
About Josep Julve
Josep Julve is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine, having authored 133 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (34 papers), Lipoproteins and Cardiovascular Health (30 papers), Lipid metabolism and disorders (22 papers), Peroxisome Proliferator-Activated Receptors (17 papers), Cancer, Lipids, and Metabolism (17 papers), Liver Disease Diagnosis and Treatment (12 papers) and Drug Transport and Resistance Mechanisms (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (784 citations), Cancer Research (368 citations) and Surgery (1.0k citations). Josep Julve has collaborated with scholars based in Spain, United States and Finland. Frequent co-authors include Francisco Blanco‐Vaca, Joan Carles Escolà‐Gil, Jesús M. Martín‐Campos, Jordi Ordóñez‐Llanos, Francesc González‐Sastre, Noemí Rotllán, Lídia Cedó, José Luís Sánchez-Quesada, Julia Peinado‐Onsurbe and Gemma Llaverı́as. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.